Evidence map›Paper›PMID 36536276›Full record

ArticleBMC bioinformatics2022

Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest.

Georg Hahn, Sanghun Lee, Dmitry Prokopenko, Jonathan Abraham, Tanya Novak, Julian Hecker, Michael Cho, Surender Khurana, Lindsey R Baden, Adrienne G Randolph and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Georg HahnDepartment of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA, 02115, USA. ghahn@hsph.harvard.edu.
Sanghun LeeDepartment of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA, 02115, USA.
Dmitry ProkopenkoGenetics and Aging Research Unit, Department of Neurology, McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA.
Jonathan AbrahamDepartment of Microbiology, Harvard Medical School, Blavatnik Institute, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
Tanya NovakDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
Julian HeckerHarvard Medical School, Harvard University, Boston, MA, 02115, USA.
Michael ChoChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Surender KhuranaFood and Drug Administration, Silver Spring, MD, 20993, USA.
Lindsey R BadenDivision of Infectious Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Adrienne G RandolphDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
Scott T WeissHarvard Medical School, Harvard University, Boston, MA, 02115, USA.
Christoph LangeDepartment of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA, 02115, USA.
Brigham and Women's Hospital · USHarvard University · USBoston Children's Hospital · USDankook University · KRMassachusetts General Hospital · USUnited States Food and Drug Administration · US

Funding

Systems Biology of Airway DiseaseP01HL132825 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2016 to 2020
$12.6M
NHLBI NIH HHS P01 HL132825
6 · The paper itself

Abstract

As of June 2022, the GISAID database contains more than 11 million SARS-CoV-2 genomes, including several thousand nucleotide sequences for the most common variants such as delta or omicron. These SARS-CoV-2 strains have been collected from patients around the world since the beginning of the pandemic. We start by assessing the similarity of all pairs of nucleotide sequences using the Jaccard index and principal component analysis. As shown previously in the literature, an unsupervised cluster analysis applied to the SARS-CoV-2 genomes results in clusters of sequences according to certain characteristics such as their strain or their clade. Importantly, we observe that nucleotide sequences of common variants are often outliers in clusters of sequences stemming from variants identified earlier on during the pandemic. Motivated by this finding, we are interested in applying outlier detection to nucleotide sequences. We demonstrate that nucleotide sequences of common variants (such as alpha, delta, or omicron) can be identified solely based on a statistical outlier criterion. We argue that outlier detection might be a useful surveillance tool to identify emerging variants in real time as the pandemic progresses.

Indexed as

COVID-19Base SequenceCluster AnalysisDatabases, FactualHumansSARS-CoV-2Machine learningNucleotide sequencesOutlier detectionSARS-CoV-2Variants of interest

Identifiers

PMID36536276
PMCPMC9761049
OpenAlexW4312113617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.